Very important histopathological factors in patients with resected non-small cell lung cancer: Necrosis and perineural invasion

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 2, 2010, Pages 93-97

  Klcgun A ^a   Turna, A ^b   Sayar, A ^b   Solak, O ^c   Urer N ^b   Gurses A ^b  

^a Baysal University   (Turkey)

^b Yedikule Teaching Hospital   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Histopathological factors; Resection; Staging; Thoracic surgery

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; NECROSIS; OVERALL SURVIVAL; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERIPHERAL NERVES; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949958499     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1186240     Document Type: Article

References (25)

1. Hammer E M. TNM classification of malignant tumors. Geneva Union Internationale Contre le Cancer 1978 41-45
2. Mountain C F. Revisions in the international system for staging lung cancer. Chest 1997 111 1710
3. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995 311 899-905
4. Nesbitt J C., Putnam Jr J B., Walsh G L., Walsh G L., Roth J A., Mountain C F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995 60 466-472
5. Hilsenbeck S G., Raub W A., Sridhar K S. Prognostic factors in lung cancer based on multivariate analysis. Am J Clin Oncol 1993 16 301-309
6. Fujisawa T, Yamaguchi Y, Saitoh Y, Hiroshima K, Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected non-small cell carcinoma of the lung with intrapulmonary metastases. Cancer 1995 76 2464-2470
7. Rigau V, Molina T J., Chaffaud C, Huchon G, Audoin J, Chevret S, Brechot J M. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer 2002 38 169-176
8. World Health Organization. International histological classification of tumours. 3rd ed. Berlin, Heidelberg Springer Verlag 1999
9. Mountain C F., Dresler C M. Regional lymph node classification for lung cancer staging. Chest 1997 111 1718-1723
10. Cicero J L., Ponn R B., Daly D T. Surgical treatment of non-small cell lung cancer. Shields TW General thoracic surgery. 5th ed. Philadelphia Lippincott Williams & Wilkins 2000 1311-1341
11. Mountain C F. New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. Chest 1995 108 246-254
12. O'Byrne K J., Cox G, Swinson D, Richardson D, Edwards J G., Lolljee J, Andi A, Koukourakis M I., Giatromanolaki A, Gatter K, Harris A L., Waller D, Jones J L. Towards a biological staging model for operable non-small cell lung cancer. Lung Cancer 2001 34 (Suppl.2) S83-S89
13. Putnam J B. The anatomic basis for lung cancer staging: the end of the beginning? Ann Thorac Surg 2001 71 1757-1758
14. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Yokose T, Nishiwaki Y. Conventional clinicopathologic factors in surgically resected non-small cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 1999 86 1976-1984
15. Fu X L., Zhu X Z., Shi D R., Xiu L Z., Wang L J., Zhao S, Qian H, Lu H F., Xiang Y B., Jiang G L. Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 1999 23 143-152
16. Sayar A, Turna A, Solak O, Klçgün A, ürer N, Gürses A. Non-anatomic prognostic factors in resected non-small cell lung carcinoma: the importance of perineural invasion as a new prognostic marker. Ann Thorac Surg 2004 77 421-425
17. Shirouzu K, Isomoto H, Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg 1993 165 233-237
18. Nangia A K., Konety B R., Wachtel S, Dhir R, Becich M J., Bahnson P R. Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomy. Urology 1997 49 968-972
19. Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y, Yamauchi H, Ogata Y. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999 29 16-22
20. Maru N, Ohori M, Kattan M W., Scardino P T., Wheeler T M. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol 2001 32 828-833
21. Margolese R G., Fsher B, Hortobagy G N., Bloomer W D. Neoplasms of the breast. Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E Cancer medicine. London B. C. Decker Inc. 2000 1747
22. Khan O A., Fitzgerald J J., Field M L., Soomro I, Soomro I, Beggs F D., Morgan W E., Duffy J P. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. Ann Thorac Surg 2004 77 1173-1178
23. Goldstraw P, Crowley J J. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol 2007 1 281-286
24. Robinson L A., Ruckdeschel J C., Wagner H, Stevens Jr C W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2ndedition). Chest 2007 132 243-265
25. Scott W J., Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II. Chest 2007 132 234S-242S